Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Product Portfolio > Development > SPI-205

SPI-205Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

A lipid suspension of leteprinim

Target Indications

  • Chemotherapy-induced neuropathy

Route of Administration

  • Subcutaneous injection

Mode of Action

Animal data is suggestive of:

  • Neuroprotective and nerve sprouting effects mediated through several nerve growth factors
  • Benefits in chemotherapy-induced neuropathy in experimental models

Status

  • Phase 1

Back to top


SPI-205